Nuvalent is also investigating the drug in a Phase III trial in TKI-naive ALK-positive NSCLC patients. Image credit: Piotr Swat / Shutterstock.com. Nuvalent’s stock price oscillated after it’s ...

The potential of digital twin technology is growing within the clinical trials landscape. Image credit: Gorodenkoff via ShutterStock.com. In recent years, automation and artificial intelligence (AI) ...

At OCT DACH 2025, industry members noted that the implementation of AI in clinical trials must be carefully thought out.

Each insight is focused on improving human-centred outcomes, aiming to cut the burden on both subjects and research sites. Credit: metamorworks / Shutterstock.com. WCG has introduced Data & Insights ...